Working… Menu

A Phase 1/ Phase 2 Study of TTHX1114(NM141) (INTREPID)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04520321
Recruitment Status : Completed
First Posted : August 20, 2020
Last Update Posted : May 26, 2021
Information provided by (Responsible Party):
Trefoil Therapeutics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 23, 2021
Actual Study Completion Date : May 18, 2021